Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jul;18(7):4004-11.
doi: 10.1128/MCB.18.7.4004.

RNA binding activity of heterodimeric splicing factor U2AF: at least one RS domain is required for high-affinity binding

Affiliations

RNA binding activity of heterodimeric splicing factor U2AF: at least one RS domain is required for high-affinity binding

D Z Rudner et al. Mol Cell Biol. 1998 Jul.

Abstract

The pre-mRNA splicing factor U2AF (U2 small nuclear ribonucleoprotein particle [snRNP] auxiliary factor) plays a critical role in 3' splice site selection. U2AF binds site specifically to the intron pyrimidine tract between the branchpoint and the 3' splice site and targets U2 snRNP to the branch site at an early step in spliceosome assembly. Human U2AF is a heterodimer composed of large (hU2AF65) and small (hU2AF35) subunits. hU2AF65 contains an arginine-serine-rich (RS) domain and three RNA recognition motifs (RRMs). hU2AF35 has a degenerate RRM and a carboxyl-terminal RS domain. Genetic studies have recently shown that the RS domains on the Drosophila U2AF subunit homologs are each inessential and might have redundant functions in vivo. The site-specific pyrimidine tract binding activity of the U2AF heterodimer has previously been assigned to hU2AF65. While the requirement for the three RRMs on hU2AF65 is firmly established, a role for the large-subunit RS domain in RNA binding remains unresolved. We have analyzed the RNA binding activity of the U2AF heterodimer in vitro. When the Drosophila small-subunit homolog (dU2AF38) was complexed with the large-subunit (dU2AF50) pyrimidine tract, RNA binding activity increased 20-fold over that of free dU2AF50. We detected a similar increase in RNA binding activity when we compared the human U2AF heterodimer and hU2AF65. Surprisingly, the RS domain on dU2AF38 was necessary for the increased binding activity of the dU2AF heterodimer. In addition, removal of the RS domain from the Drosophila large-subunit monomer (dU2AF50DeltaRS) severely impaired its binding activity. However, if the dU2AF38 RS domain was supplied in a complex with dU2AF50DeltaRS, high-affinity binding was restored. These results suggest that the presence of one RS domain of U2AF, on either the large or small subunit, promotes high-affinity pyrimidine tract RNA binding activity, consistent with redundant roles for the U2AF RS domains in vivo.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
SDS-polyacrylamide gel electrophoresis of purified recombinant U2AF proteins. Samples from the final preparations of U2AF monomers and heterodimers were run on an SDS–12% polyacrylamide gel and stained with Coomassie blue. All individually purified monomers are His6 tagged. dU2AF50 is His6 tagged in the dU2AF heterodimers, and hU2AF35 is His6 tagged in the hU2AF heterodimer. Marker sizes are indicated in kilodaltons.
FIG. 2
FIG. 2
dU2AF38 interacts weakly with pyrimidine tract RNA. For electrophoretic mobility shift analysis of dU2AF38 with MINX (WT and MUT) pyrimidine tract RNA, 200 pM 32P-labeled RNA oligonucleotide was incubated in the presence (+) or absence (−) of 5 μM dU2AF38 complexed with the His6-dU2AF50 interaction domain (L/d38). Protein-RNA complexes (C) and unbound RNA (F) were separated by electrophoresis through a native polyacrylamide gel and visualized by autoradiography.
FIG. 3
FIG. 3
The dU2AF heterodimer binds pyrimidine tract RNA with higher affinity than the dU2AF50 monomer. (A) Electrophoretic mobility shift analysis of dU2AF heterodimer and dU2AF50 monomer interaction with MINX-WT pyrimidine tract RNA. dU2AF50 monomer protein concentrations were 5,000, 1,000, 200, 40, and 8 nM (lanes 2 to 6). dU2AF heterodimer concentrations were 5,000, 1,000, 200, 40, and 8 nM (lanes 7 to 11). Proteins were incubated with 100 pM 32P-labeled RNA oligonucleotide. Protein-RNA complexes (C) and unbound RNA (F) were separated by electrophoresis through a native polyacrylamide gel and visualized by autoradiography. Occasionally, the dU2AF50/dU2AF38 heterodimer-RNA complex appeared to be retained in the sample well. However, this effect was variable. The sequence of the MINX-WT pyrimidine tract oligonucleotide is displayed below the autoradiogram. The apparent Kd for the dU2AF50 monomer was ∼2.2 × 10−6 M. The apparent Kd for the dU2AF heterodimer was ∼1.0 × 10−7 M. (B) Electrophoretic mobility shift analysis of dU2AF heterodimer and dU2AF50 monomer interaction with MINX-MUT pyrimidine tract RNA. Protein concentrations were identical to those in panel A. The sequence of the MINX-MUT pyrimidine tract oligonucleotide is displayed below the autoradiogram. The apparent Kd for the dU2AF50 monomer could not be determined. The apparent Kd for the U2AF heterodimer was ∼1.1 × 10−6 M. Although it may appear that U2AF binding is cooperative, this is due to the broad titration of protein used in this experiment. When a finer titration is used, we detect no evidence of cooperative binding (Fig. 5B and data not shown) (9).
FIG. 4
FIG. 4
The hU2AF heterodimer binds pyrimidine tract RNA with higher affinity than the hU2AF65 monomer. (A) Electrophoretic mobility shift analysis of hU2AF heterodimer and hU2AF65 monomer interaction with MINX-WT pyrimidine tract RNA. hU2AF65 monomer protein concentrations were 2,000, 400, 80, 16, 3.2, 0.64, and 0.128 nM (lanes 2 to 8). hU2AF heterodimer concentrations were 400, 80, 16, 3.2, 0.64, and 0.128 nM (lanes 9 to 14). Proteins were incubated with 100 pM 32P-labeled RNA oligonucleotide. Protein-RNA complexes (C) and unbound RNA (F) were separated by electrophoresis through a native polyacrylamide gel and visualized by autoradiography. The apparent Kd for hU2AF65 was ∼3.8 × 10−8 M. The apparent Kd for hU2AF heterodimer was ∼2.5 × 10−9 M. (B) Electrophoretic mobility shift analysis of hU2AF heterodimer and hU2AF65 monomer interaction with MINX-MUT pyrimidine tract RNA. Protein concentrations were identical to those in panel A. The apparent Kd for hU2AF65 was ∼2.6 × 10−7 M. The apparent Kd for the hU2AF heterodimer was ∼6.1 × 10−9 M.
FIG. 5
FIG. 5
At least one RS domain on U2AF is required for high-affinity RNA binding. (A) Electrophoretic mobility shift analysis of dU2AF50ΔRS monomer and dU2AF50ΔRS/dU2AF38 heterodimer interaction with MINX-WT pyrimidine tract RNA. dU2AF50ΔRS monomer protein concentrations were 5,000, 1,000, 200, and 40 nM (lanes 1 to 4). dU2AF50ΔRS/dU2AF38 heterodimer concentrations were 5,000, 1,000, 200, and 40 nM (lanes 5 to 8). Proteins were incubated with 100 pM 32P-labeled RNA oligonucleotide. Protein-RNA complexes (C) and unbound RNA (F) were separated by electrophoresis through a native polyacrylamide gel and visualized by autoradiography. The apparent Kd for dU2AF50ΔRS could not be determined. The apparent Kd for dU2AF50ΔRS/dU2AF38 was ∼1.7 × 10−7 M. (B) Electrophoretic mobility shift analysis of dU2AF50 and dU2AF50/dU2AF38ΔRS heterodimer interaction with MINX-WT pyrimidine tract RNA. dU2AF50 monomer protein concentrations were 4,000, 1,600, 640, 256, and 102 nM (lanes 2 to 6). dU2AF50/dU2AF38ΔRS heterodimer protein concentrations were 4,000, 1,600, 640, 256, and 102 nM (lanes 7 to 11). The apparent Kd for dU2AF50 was ∼8.0 × 10−7 M. The apparent Kd for the dU2AF50/dU2AF38ΔRS heterodimer was ∼3.0 × 10−7 M.

Similar articles

Cited by

References

    1. Bentley R C, Keene J D. Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A′ protein. Mol Cell Biol. 1991;11:1829–1839. - PMC - PubMed
    1. Birney E, Kumar S, Krainer A R. Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res. 1993;21:5803–5816. - PMC - PubMed
    1. Black D L. Finding splice sites within a wilderness of RNA. RNA. 1995;1:763–771. - PMC - PubMed
    1. Blumenthal, T. Personal communication.
    1. Caceres J F, Krainer A R. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J. 1993;12:4715–4726. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources